Digital Health Global

MARCH 16, 2023

About Wellington Partners Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totaling more than €1.2 Forbion manages well over EUR 2.3

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Healthcare Innovation Consortium

OCTOBER 24, 2023

Inna: Our aim is to improve patient and clinician access to modern, innovative and reliable medical technology. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded. We ensure that everything we do has the patient at the heart.

BioTech 60

BioTech Drug Development Healthcare Innovation Medical Technology 60

Healthcare IT Today

DECEMBER 27, 2022

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A The company operates as the strategic headquarters for the region.

Pharmaceuticals 59

Pharmaceuticals Drug Development Medical Technology Healthcare IT 59

Lloyd Price

FEBRUARY 22, 2024

Virtual Reality (VR) & Augmented Reality (AR): Company: AppliedVR (EaseVRx) - This VR platform uses immersive experiences to distract users from pain and promote relaxation, reducing reliance on medication. Opioid crisis: The public's negative perception of opioids has made investors cautious about pain medications, even non-opioids.

Pain management 56

Pain management Mental health Telehealth healthcare technology 56